Ceramide Serums and Barrier Repair: Ratio Matters More Than Percentage

A ceramide serum can list ceramides on the pack, pass a stability test, feel pleasant on the skin and still not deliver what the customer bought it for. The reason is usually the same: the ceramide is there, but the system it sits in is not.

Ceramides are one component of a mixture. Their behaviour depends on what they are mixed with and in what proportion, and that proportion is a formulation decision that is much harder to get right than the percentage on the label. This article is about why the ratio is the product.

The ratio is the formulation, the percentage is the label

The skin's own barrier lipids are not a single material. They are a mixture dominated by three classes: ceramides, cholesterol and free fatty acids, present in a characteristic proportion.

The proportion matters because the mixture has to form a structured, layered arrangement rather than a disordered one. Take one component and change its share substantially and the structure changes - which is why a formula that pushes ceramide content up without adjusting the other two can end up less effective than a formula with far less ceramide in the right company.

This is also why "10% ceramides" is not automatically a strong claim and "1% ceramides" is not automatically a weak one. The number describes one input. The ratio describes the system the input operates in.

For a brand, the practical consequence is that the ceramide level is the wrong thing to negotiate. The list of what is in the base alongside the ceramide - and the cholesterol and fatty acid sources - is the thing to ask about.

What a ceramide actually is

Ceramides are a family of lipids built from a long-chain base and a fatty acid, joined by an amide bond. The variation comes from which base and which fatty acid, and the resulting molecules differ in chain length, saturation and how they pack.

That structural variety is why the ingredient list can carry several ceramide entries rather than one. Different members of the family occupy slightly different positions in the barrier arrangement.

For formulation purposes, three practical facts follow:

• They are waxy solids at room temperature. Ceramides are not liquids and they are not water-soluble. They need to be melted or dispersed, and they need an oil phase to live in.
• They are expensive per kilogram. Even at low inclusion, a real ceramide contributes meaningfully to the fill cost - see our cost breakdown article for how that lands in a quotation.
• They are identified by number or trade name. The INCI name usually carries a number, and the number is not a ranking - it identifies the specific molecule.

Which ceramides, and why the numbering matters

The numbering system is a shorthand for the structure, and the common commercial materials cluster into a few groups. Ceramide NP, ceramide AP and ceramide EOP are the three that appear most often together, and they are the three usually referred to when a supplier describes a "skin-identical" blend.

Other entries on ingredient lists may be plant-derived materials rather than the numbered molecules. They are legitimate ingredients and they are not the same thing, which matters if your claim depends on matching the skin's own composition. The honest version of that claim is about the blend resembling the barrier composition, not about the ceramide being chemically identical to a human one.

Then there is the regulatory side. Ceramides are cosmetic ingredients in most markets, and the composition of a plant-derived material can vary with the source. A supplier who can state the ceramide content of their material, and how it is measured, is worth more than one who states a percentage and stops there.

The 3:1:1 ratio and where it comes from

The proportion most often quoted for a barrier-support blend is roughly 3:1:1 ceramides to cholesterol to fatty acids, or a variant close to it.

Two things are worth saying about that number.

First, it comes from work on how the barrier lipids are arranged rather than from a cosmetic marketing brief. It describes the composition of the structured lipid mixture in skin.

Second, a formula cannot reproduce the barrier simply by dosing those three materials in that ratio. A serum or cream is a delivery system, not a reconstructed tissue. What the ratio gives you is a sensible starting point for building a blend that behaves in a way consistent with barrier support, instead of a mixture that fights itself.

The practical version of the rule: if the formula contains ceramides but no cholesterol source and no meaningful fatty acid contribution, the ratio is not 3:1:1. It is something else, and it is unlikely to have been designed.

The other two thirds: cholesterol and fatty acids

Cholesterol is the second component and it is easy to overlook because it sounds unglamorous. In barrier-support positioning it is not optional - it is part of the mixture, and it also contributes to the texture, helping the system spread rather than sit on the surface.

Fatty acids are the third. In practice they arrive through the emollient and oil phase rather than as a labelled ingredient: a shea butter, a squalane, a triglyceride blend, a plant oil. That makes them easy to under-count, because the formulator sees them as texture ingredients rather than as part of the barrier story.

This is where a ceramide brief often goes wrong. The brand asks for ceramides at a level. The formulator supplies ceramides at that level in a base chosen for sensory reasons. Nobody specifies the other two components, and the resulting product has a ceramide entry on the pack and a lipid mixture that was never designed as a mixture.

Delivery forms and why they change the result

Ceramides are supplied in several physical forms, and the form affects both processing and performance:

• Powder. The most economical and the hardest to handle. Powder has to be melted or dispersed, and incomplete dispersion produces a formula that is uneven and can develop a waxy grain over time.
• Premixed dispersion. Ceramide already dispersed in a carrier oil or a surfactant blend. Easier to process, and the supplier has done the dispersion step, at a price.
• Liposomal or vesicular systems. The ceramide is packaged into structured particles in a water phase. This is the route that allows a ceramide contribution in a base with little or no oil, and it is the one behind most products positioned as a light, watery barrier serum.
• Encapsulated formats. Where the product is a single-dose capsule, the fill itself is the delivery vehicle and the dispersion quality in the fill is the thing to specify. See our encapsulation article.

Why ceramides push a formula towards an emulsion

A ceramide has nowhere to go in a pure water gel. It is not soluble, it will not stay dispersed without help, and a surfactant load high enough to force it into solution changes the product into something else entirely.

So a ceramide product is almost always an emulsion: an oil-in-water cream or lotion for a comfortable skin feel, or a water-in-oil system where occlusivity is part of the positioning. The choice between them is a texture decision with real consequences for what the product can claim about the feel.

That also means the ceramide formulation inherits all the standard emulsion problems - phase stability, preservative partitioning between phases, viscosity drift. Our emulsion formulation article covers the base-level decisions, and our stability article covers the testing that catches them.

If your brief says "light serum" and "ceramides" without qualification, the formulator has to choose between a very low ceramide contribution and a texture that is not really a serum. That is a brief problem, not a technical one, and it is worth resolving before sampling.

Pseudoceramides and the cheaper route

A separate class of materials is sold as pseudo-ceramides. These are synthetics designed to behave like ceramides in a formula - structuring the oil phase, contributing a similar skin feel - without carrying the ceramide cost.

They are legitimate cosmetic ingredients with their own INCI names and they are not ceramides. A formula built on pseudoceramides is cheaper and can be perfectly good, but the pack cannot claim a ceramide content it does not have, and a comparison against a genuine ceramide product has to be made on the sensory result rather than on composition.

The failure mode is a supplier describing a pseudoceramide by a trade name that sounds like a ceramide and letting the brand infer the rest. Ask for the INCI name and read it. It is one line and it settles the question.

Ratio compared

Crystallisation, haze and the stability question

Lipids that are solid at room temperature have a tendency to crystallise, and a crystallising ceramide base shows up in three ways.

The first is grain: fine crystals that form over time and feel like grit on the skin. The second is haze or a visible bloom in a translucent product. The third is a change in viscosity as the crystal network develops.

None of these is necessarily a defect at release. They develop over weeks and months, which is why the stability protocol for a ceramide product needs a low-temperature arm and a full twelve-week observation rather than a two-week accelerated run. A ceramide formula that passes a heated accelerated study and fails at 5 degrees Celsius has not passed.

The countermeasures are standard: choose a dispersion that is stable in the chosen oil, keep the ceramide level within what the base can carry, avoid a large temperature difference between the oil phase and the water phase at the point of mixing, and test the finished pack rather than the bulk.

The pH and preservative questions

Ceramides are not pH-sensitive in the way an acid active is, so the pH of the formula is set by what else is in it rather than by the ceramide. That is convenient and it removes one variable.

The preservative question is less simple. In an emulsion, a preservative partitions between the water phase and the oil phase, and only the fraction in the water phase is doing useful work. A rich lipid phase takes up more of certain preservatives, which can leave the water phase under-protected even though the batch was dosed correctly.

The answer is preservative efficacy testing on the finished formula rather than a calculation, and it is the same test a plain cream needs - see our preservative article. Where the product is positioned as suitable for reactive or sensitive skin, an additional set of formulation choices applies, covered in our barrier repair article.

Claims: what "barrier repair" is allowed to mean

This is where ceramide products most often overreach.

Cosmetic claims can describe the appearance and the feel of the skin. "Supports the appearance of a comfortable, balanced complexion", "skin feels softer and more supple", "helps the skin look less tight" - these are appearance claims and they are supportable with consumer testing.

"Repairs the skin barrier" describes a physiological process. So does "restores the barrier", "rebuilds the lipid matrix" and "strengthens the skin's defences". Those are mechanism statements, and in most markets they move the product out of the cosmetic zone.

There is a middle route that works well and stays inside the rules: describe the outcome the customer can see and feel, and let the ingredient list carry the technical story. Our efficacy testing article and microbiome article both cover versions of this boundary.

Testing to commission

• Stability on the finished pack with both a high and a low temperature arm, observed for the full period. Crystallisation appears late.
• Preservative efficacy on the finished formula, not on the water phase alone.
• Dispersion check on the bulk - a microscopic look for undispersed ceramide is cheap and catches the most common processing fault.
• Consumer use testing against the appearance claims you intend to print, on a panel that includes the skin type you are targeting.
• Pack compatibility where the format is a capsule or a low-surface-area container, since lipid migration into a shell or a liner is a real mechanism - see our packaging compatibility article.

How to write the ceramide brief

A brief that produces a good result names four things: the ceramide materials you want and at what as-supplied level, the cholesterol source, the intended fatty acid contribution through the emollient phase, and the physical form of the product you are asking for. Then it states the claim, because the claim and the texture are in tension and the formulator needs to know which one wins.

What to avoid: a brief that specifies only a percentage. That single number does not describe a system, and it puts the formulator in a position where the only way to hit it is to sacrifice something else.

Where our ceramide capability fits

We build ceramide bases in emulsions and in single-dose capsule fills, with the three-component mixture designed rather than assumed, and with the low-temperature stability arm run as standard. Formats include a ceramide moisturising facial essence capsule and a custom moisturising face serum oil capsule.

We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing, and full custom formula development - whichever matches where your brand is today.

Tell us what the product has to feel like and what it has to claim, and we will come back with the mixture rather than a single number. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319.

General manufacturing information, not regulatory or legal advice. Claim limits vary by market.